13 results match your criteria: "Centre for Immunization Surveillance[Affiliation]"

Post-exposure prophylaxis for the prevention of measles: A systematic review.

Vaccine

January 2025

Centre for Immunization Surveillance and Programs, Infectious Disease and Vaccine Program Branch, Public Health Agency of Canada, 130 Colonnade Rd S, Nepean, ON K1A0K9, Canada; Department of Pediatrics, Faculty of Medicine, McGill University. Electronic address:

Background: In susceptible individuals, post-exposure prophylaxis (PEP) is often recommended following exposure to measles, however the data that these recommendations are based on are limited. The objective of this systematic review was to evaluate the efficacy/effectiveness and safety of immunoglobulins (Ig) or measles-containing vaccine (MCV) for the prevention of measles.

Methods: Prospective studies evaluating the use of Ig or MCV as PEP in susceptible individuals exposed to measles were eligible for inclusion.

View Article and Find Full Text PDF

Approach to prevention of respiratory syncytial virus disease in infants by passive immunization.

Can Fam Physician

December 2024

Senior Medical Advisor in the Centre for Immunization Surveillance and Programs at the Public Health Agency of Canada, Associate Professor in the Department of Pediatrics in the Section of Allergy and Clinical Immunology at the University of Manitoba in Winnipeg, and Adjunct Professor in the Department of Pediatrics in the Division of Allergy and Immunology at the University of British Columbia in Vancouver.

Article Synopsis
  • The objective is to help family physicians effectively discuss RSV immunizations with their patients.
  • There are three preventive options for severe RSV disease in infants: palivizumab for high-risk infants, nirsevimab for all infants, and the RSVpreF vaccine for pregnant individuals.
  • Family doctors need to understand each immunization option's specifics, including recommendations and patient considerations, to support informed choices for parents and infants.
View Article and Find Full Text PDF

Background: The National Advisory Committee on Immunization (NACI) reviews the evolving evidence on influenza immunization and provides annual recommendations regarding the use of seasonal influenza vaccines. The updates the NACI recommendations from the previous year.

Objective: To summarize the 2024-2025 NACI seasonal influenza vaccine recommendations and to highlight new and updated information.

View Article and Find Full Text PDF

Confidence and barriers: Analysis of factors associated with timely routine childhood vaccination in Canada during the COVID-19 pandemic.

Vaccine

October 2024

Behavioural Science Office, Centre for Surveillance, Integrated Insights, and Risk Assessment, Data, Surveillance and Foresight Branch, Public Health Agency of Canada, Canada. Electronic address:

Routine childhood vaccination is a crucial component of public health in Canada and worldwide. To facilitate catch-up from the global decline in routine vaccination caused by the COVID-19 pandemic, and toward the ongoing pursuit of coverage goals, vaccination programs must understand barriers to vaccine access imposed or exacerbated by the pandemic. We conducted a regionally representative online survey in January 2023 including 2036 Canadian parents with children under the age of 18.

View Article and Find Full Text PDF

Human papillomavirus (HPV) infections, the most common sexually transmitted infections, are associated with various health outcomes including anogenital warts and cancers. Despite significant investments in HPV vaccination programs, ensuring adequate vaccination coverage for adolescents remains a challenge in Canada. This analysis used data collected through the 2019 Childhood National Immunization Coverage Survey (CNICS) to determine national estimates of HPV non-vaccination and investigate determinants of HPV non-vaccination for adolescents aged 14-years old in Canada, both overall and stratified by gender.

View Article and Find Full Text PDF
Article Synopsis
  • New vaccine products for invasive pneumococcal disease (IPD) were authorized in Canada, prompting a study to examine trends in IPD incidence and severity in Ontario across different time periods, including pre- and post-vaccine introduction and during the COVID-19 pandemic.
  • The analysis revealed a decline in IPD incidence and hospitalizations among children under 5 years after the introduction of the 13-valent vaccine (PCV13), but an increase in case fatality rates and hospitalizations among older adults.
  • Despite the overall decrease in cases from PCV13 serotypes, there was a rise in cases from newer serotypes, highlighting the need for ongoing surveillance and possible adjustments to vaccination strategies.
View Article and Find Full Text PDF

Background: The Canadian Adverse Events Following Immunization Surveillance System (CAEFISS) is a comprehensive vaccine safety surveillance system that includes both passive and active surveillance of vaccines administered in Canada. This work presents a summary of adverse events following immunization (AEFI) nationally for 2018 and 2019.

Methods: Data extracted from CAEFISS included all AEFI reports received by the Public Health Agency of Canada by April 30, 2022, for vaccines marketed in Canada and administered between January 1, 2018, and December 31, 2019.

View Article and Find Full Text PDF

Background: Seasonal influenza vaccines (SIV) authorized for use in Canada have all undergone rigorous regulatory assessments for safety and effectiveness. Serious adverse events following immunization (AEFI) can occur, though they are rare. Continuous safety surveillance of vaccines during the post-marketing phase is a critical component of vaccination programs.

View Article and Find Full Text PDF

Background: The coronavirus disease 2019 (COVID-19) pandemic in Canada has evolved rapidly. Since late 2020, COVID-19 vaccines have been relied on to protect against severe outcomes in the presence of circulating variants of concern (VOC).

Objective: This surveillance report provides a retrospective descriptive analysis of national trends in COVID-19 cases and severe outcomes by vaccination status, contextualizing trends against case demographics and circulating VOCs, from December 2020 to January 2022.

View Article and Find Full Text PDF

Background: COVID-19 vaccination efforts are critical in mitigating the impact of the virus, but despite proven safety and efficacy, vaccination rates among children in Canada are lower than in adults, prompting a need to explore determinants of childhood COVID-19 non-vaccination to improve uptake.

Method: This study analyzed data from the Canadian COVID-19 Immunization Coverage Survey 2022. Using multivariable logistic regression, it examined the association between COVID-19 non-vaccination among children aged 5-17 and factors such as parental sociodemographic characteristics, vaccine knowledge, attitudes, and beliefs (KAB), and vaccination history.

View Article and Find Full Text PDF

Determinants of non-vaccination against seasonal influenza during pregnancy.

Can J Public Health

June 2024

Department of Obstetrics, Gynecology, and Reproductive Sciences, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Objective: The objective of this study was to identify the determinants of influenza non-vaccination during pregnancy in Canada.

Methods: Biological mothers of children born between December 2018 and March 2019 were surveyed about vaccinations they had received during pregnancy, reasons for non-vaccination, obstetrical history, and demographics. Simple and multiple logistic regression models were used to measure associations between various sociodemographic factors as well as obstetrical history, and non-vaccination against influenza.

View Article and Find Full Text PDF

Introduction: Identifying and monitoring adverse events following vaccination contributed to the safety and effectiveness of COVID-19 mass vaccination campaigns. In March 2021, international reports emerged of an adverse event following vaccination with adenovirus vector COVID-19 vaccines (ChAdOx1-S [recombinant] and Ad26.COV2.

View Article and Find Full Text PDF

Objective: The purpose of this study was to measure the proportion of non-vaccination for pertussis in mothers in Canada who had been advised by their prenatal care provider to get vaccinated, and to identify sociodemographic factors and beliefs associated with non-vaccination.

Methods: The Survey on Vaccination during Pregnancy (part of childhood National Immunization Coverage Survey) included biological mothers of children born from September 2018 to March 2019. This analysis was restricted to 2657 mothers who had been advised by their prenatal care provider to get vaccinated against pertussis during pregnancy and knew whether or not they had been vaccinated.

View Article and Find Full Text PDF